EMSN EMS-CHEMIE HOLDING AG
EMS-CHEMIE HOLDING AG engages in the polymers and specialty chemicals businesses in the Americas, Europe, Asia, and internationally. The company manufactures and sells polymers, such as polyamide granulates used in automotive and construction applications in the electro and electronics, optics, and other industrial sectors, as well as offers feasibility studies, design, prototypes, component testing, and mould optimization services. It also offers bonding, coating, sealing, and damping services for the automotive industry; and develops and produces fibers, bonding agents, fusible adhesives, and adhesive yarns for technical and textile applications, powder coatings, and reactive diluents. The company was founded in 1936 and is based in Domat/Ems, Switzerland.…
Industry Peers
Specialty ChemicalsKey Statistics
About EMS-CHEMIE HOLDING (SWX: EMSN)
›
EMS-CHEMIE HOLDING (SWX: EMSN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 2,617 employees.
The shares were at 830.50 CHF on 19 November 2026, up 49.1% over 52 weeks. Its 52-week range is 530.00 CHF to 900.00 CHF: the price is 7.7% below the high and 56.7% above the low.
At a market capitalisation of 19.42B CHF, it trades at 41.0 times trailing earnings and 36.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 32.8, a premium of 25% for EMSN. It pays a dividend yielding 1.76% (it pays out 69% of its earnings), against a median of 1.91% among the dividend payers in that peer group.
EMS-CHEMIE HOLDING reports return on equity of 25.1%, an operating margin of 29.9% and revenue down 0.9% year over year.
It holds more cash than debt, a net cash position of 750.39M CHF. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 7 analysts cover the stock, with an average rating of Underperform; their mean price target of 776.57 CHF is 6.5% below the current price. The next earnings report is expected on 5 February 2027.